Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Julie Rich Ingelfinger, M.D.

Co-Author

This page shows the publications co-authored by Julie Ingelfinger and Rafail Kushak.
Connection Strength

0.949
  1. Platelet thrombus formation in eHUS is prevented by anti-MBL2. PLoS One. 2019; 14(12):e0220483.
    View in: PubMed
    Score: 0.213
  2. Both platelets and fibrin deposition are increased in the glomeruli of mice after treatment with Shiga toxin-2. Kidney Int. 2017 12; 92(6):1556-1557.
    View in: PubMed
    Score: 0.184
  3. Shiga toxin-1 Decreases Endothelial Cell Tissue Factor Pathway Inhibitor Not Co-localized with Tissue Factor on the Cell Membrane. Thromb Res. 2015 Jun; 135(6):1214-7.
    View in: PubMed
    Score: 0.153
  4. Shiga toxin downregulates tissue factor pathway inhibitor, modulating an increase in the expression of functional tissue factor on endothelium. Thromb Res. 2013 Jun; 131(6):521-8.
    View in: PubMed
    Score: 0.134
  5. Role of the renin angiotensin system in TNF-alpha and Shiga-toxin-induced tissue factor expression. Pediatr Nephrol. 2008 Feb; 23(2):221-31.
    View in: PubMed
    Score: 0.092
  6. Up-regulation of tissue factor activity on human proximal tubular epithelial cells in response to Shiga toxin. Kidney Int. 2005 Jun; 67(6):2254-66.
    View in: PubMed
    Score: 0.077
  7. Detached endothelial cells and microparticles as sources of tissue factor activity. Thromb Res. 2005; 116(5):409-19.
    View in: PubMed
    Score: 0.077
  8. Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome. J Thromb Haemost. 2005 Apr; 3(4):752-62.
    View in: PubMed
    Score: 0.019
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.